Fondazione Ricerca Traslazionale

This study is testing if a two-drug combination (atezolizumab plus bevacizumab) works better than a single drug (atezolizumab) to control advanced non-small cell lung cancer that has spread. It will involve 206 patients in Italy who have not had chemotherapy before and whose tumo…

This study is testing whether adding an experimental cancer vaccine called Tedopi to standard second-line drugs (docetaxel or nivolumab) can help control metastatic lung cancer that has progressed after initial treatment. It will involve about 105 patients who have a specific gen…